Introduction This systematic review aimed to retrieve patients diagnosed with de novo
immune thrombocytopenic purpura (ITP) after COVID‐19 immunization to determine their …

If one had any doubts before the pandemic regarding the correlation between infections and
autoimmunity, COVID-19 left us fascinated on the strong bond between the two entities. The …

Thrombotic Thrombocytopenia Syndrome (TTS) has emerged as a new adverse event
following immunization in individuals vaccinated with COVID-19 non-replicant adenovirus …

Immune thrombocytopenic purpura (ITP) has been described following both coronavirus
disease 2019 (COVID-19) infection and COVID-19 vaccination. ITP is a challenging …

Abstract Background COVID-19 (Coronavirus disease 2019) pandemic is the main medical
problem around the world from the end of 2019. We found until now many symptoms of this …

Introduction Immune thrombocytopenic purpura (ITP) is characterized by a decrease in
platelet counts and can be triggered by various factors, such as viral infections and …

While widespread coronavirus disease 2019 (COVID-19) vaccination has helped achieve
some control of the pandemic, vaccines have presented with side effects of their own, both …

Thrombosis with thrombocytopenia syndrome (TTS) is a very rare adverse event following
immunization (AEFI). The benefits of COVID-19 vaccination with a non-replicating …

Abstract The “Severe Acute Respiratory Syndrome-related Coronavirus type 2”(SARS-CoV-
2), the infectious agent responsible for the still ongoing “Coronavirus Disease 2019”(COVID …

Background: COVID-19 (Coronavirus disease 2019) pandemic is the main medical problem
around the world from the end of 2019. We found until now many symptoms of this disease …